Merck Overview
- Year Founded
-
1891
- Status
-
Public
- Employees
-
62,604
- Stock Symbol
-
MRK
- Investments
-
110
- Share Price
-
$132.91
- (As of Wednesday Closing)
Merck General Information
Description
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Contact Information
Website
www.merckgroup.comCorporate Office
- Frankfurter Strasse 250
- 64293 Darmstadt
- Germany
Corporate Office
- Frankfurter Strasse 250
- 64293 Darmstadt
- Germany
Merck Stock Performance
As of 21-May-2025, Merck’s stock price is $132.91. Its current market cap is $57.8B with 435M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $132.91 | $131.64 | $121.30 - $196.12 | $57.8B | 435M | 399K | $6.97 |
Merck Financials Summary
As of 31-Mar-2025, Merck has a trailing 12-month revenue of $22.9B.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 67,523,658 | 71,806,478 | 78,270,177 | 92,853,805 |
| Revenue | 22,882,784 | 22,892,883 | 22,716,009 | 23,374,794 |
| EBITDA | 6,325,078 | 5,919,081 | 5,859,438 | 6,578,629 |
| Net Income | 3,025,131 | 3,004,988 | 3,055,781 | 3,496,967 |
| Total Assets | 53,438,031 | 53,659,171 | 53,606,367 | 52,048,816 |
| Total Debt | 9,414,133 | 10,687,714 | 10,903,664 | 11,150,790 |
Merck Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Merck Comparisons
Industry
Financing
Details
Merck Competitors (28)
One of Merck’s 28 competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | ||||
| Pfizer India | Corporation | Mumbai, India | ||||
| Cipla | Corporation | Mumbai, India | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| Eisai | Corporation | Tokyo, Japan |
Merck Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Merck Patents
Merck Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4553132-A1 | Liquid crystal medium | Pending | 08-Nov-2023 | ||
| US-20250154412-A1 | Liquid crystal medium | Pending | 08-Nov-2023 | ||
| EP-4538349-A1 | Liquid-crystalline medium | Pending | 13-Oct-2023 | ||
| JP-2025072310-A | Liquid crystal medium | Pending | 13-Oct-2023 | ||
| EP-4527907-A1 | Liquid-crystal medium | Pending | 19-Sep-2023 | C09K19/42 |
Merck Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Merck Investments & Acquisitions (110)
Merck’s most recent deal was a Merger/Acquisition with SpringWorks Therapeutics for . The deal was made on 28-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SpringWorks Therapeutics | 28-Apr-2025 | Merger/Acquisition | Drug Discovery | ||
| Abbisko Therapeutics (Global Rights of CSF-1R Inhibitor) | 01-Apr-2025 | Corporate Asset Purchase | Buildings and Property | ||
| HUB Organoids | 24-Dec-2024 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Ambrosia Biosciences | 10-Dec-2024 | Early Stage VC | Drug Discovery | ||
| Fuse Vectors | 24-Nov-2024 | Grant | Biotechnology |
Merck ESG
Risk Overview
Risk Rating
Updated January, 28, 2025
15.5 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,631
Rank
Percentile
Pharmaceuticals
Industry
of 843
Rank
Percentile
Pharmaceuticals
Subindustry
of 419
Rank
Percentile
Merck Exits (24)
Merck’s most recent exit was on 05-Aug-2024 from IDRx. The exit was categorized as with 10 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| IDRx | 05-Aug-2024 | Completed |
|
||
| MoonLake Immunotherapeutics | 01-Mar-2021 | Completed |
|
||
| breathe ilo | 31-Jan-2020 | Completed |
|
||
| Lisen Imprinting Diagnostics | 29-Oct-2019 | Completed |
|
||
| Akili Labs | 29-Aug-2019 | Accelerator/Incubator | Completed |
Merck Affiliates
Subsidiaries (19)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Exelead | Indianapolis, IN | 2017 | |
| ConnectMed | Kenya | 2015 | |
| Merck Innovation Center | Darmstadt, Germany | 2015 | |
| HUB Organoids | Utrecht, Netherlands | 2013 | |
| M Ventures | Amsterdam, Netherlands | 2009 |
Merck FAQs
-
When was Merck founded?
Merck was founded in 1891.
-
Where is Merck headquartered?
Merck is headquartered in Darmstadt, Germany.
-
What is the size of Merck?
Merck has 62,604 total employees.
-
What industry is Merck in?
Merck’s primary industry is Pharmaceuticals.
-
Is Merck a private or public company?
Merck is a Public company.
-
What is Merck’s stock symbol?
The ticker symbol for Merck is MRK.
-
What is the current stock price of Merck?
As of 21-May-2025 the stock price of Merck is $132.91.
-
What is the current market cap of Merck?
The current market capitalization of Merck is $57.8B.
-
What is Merck’s current revenue?
The trailing twelve month revenue for Merck is $22.9B.
-
Who are Merck’s competitors?
Novartis, Pfizer India, Cipla, AbbVie, and Eisai are some of the 28 competitors of Merck.
-
What is Merck’s annual earnings per share (EPS)?
Merck’s EPS for 12 months was $6.97.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
